Skip to main content
Surgical Case Reports
Fig. 6 | Surgical Case Reports

Fig. 6

From: Long-term survival of an adult patient with undifferentiated embryonal sarcoma of the liver with multidisciplinary treatment: a case report and literature review

Fig. 6

This figure shows the progress in chemotherapy (black bars). Gray bars indicate drug dose reductions. In the second and third operations, palliative partial hepatectomy of one rapidly growing tumor (yellow circles) is performed. The patient is administered doxorubicin (75 mg/m2/dose every 3 weeks for 3 cycles); gemcitabine (900 mg/m2/dose, days 1 and 8) and docetaxel (70 mg/m2/dose every 3 weeks for 16 cycles, day 8); eribulin (1.4 mg/m2/dose every 3 weeks for 6 cycles, days 1 and 8); trabectedin (1.2 mg/m2/dose every 3 weeks for 3 cycles); ifosfamide (2 g/m2/dose, days 1–5) and mesna (400 mg/m2/dose given 4 weeks for 15 cycles, days 1–5); pazopanib (800 mg/day dose given 4 weeks for 2 cycles); and CDDP (100 mg/m2/dose given 3 weeks for 3 cycles). GEM gemcitabine, DOC docetaxel, CDDP cisplatin

Back to article page